We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Clene Inc
14 own
8 watching
Current Price
$5
$0.28
(5.93%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
44.61M
52-Week High
11
52-Week Low
3.82000
Average Volume
0.04M
Dividend Yield
--
P/E Ratio
--
Market Capitalization44.61M52-Week High1152-Week Low3.82000Average Volume0.04MDividend Yield--P/E Ratio--What does the Clene Inc do?
Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease and multiple sclerosis. It specializes in the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its CNM-Au8 is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the nicotinamide adenine dinucleotide pathway while reducing oxidative stress. Its CNM-ZnAg is a broad-spectrum antiviral, antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions under development to treat infectious disease and to provide immune support for symptom resolution. Its CNM-AgZn17 is a gel polymer suspension of Zn2+ and Ag+ under development for treatment of infectious diseases and to support wound healing.
Read More
How much money does Clene Inc make?
News & Events about Clene Inc.
Globe Newswire
1 year ago
Peer-reviewed publication includes data from the CNM-Au8 Phase 2 RESCUE-ALS trial and its open-label-extension, up to 120 weeks of patient follow-up SALT LAKE CITY, June 26, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, Clene) and its wholly owned subsidiary Clene ...
Globe Newswire
1 year ago
Investment led byVivo Capitalwith participation fromSymBiosis,Acuta Capital Partners,AIGH Capital,Serrado Capital LLC,and other new biotech investors, with support from existing insiders$40 millionunderwritten public offering with up to an additionalpotential $130.8 millionin proceeds through future...
Globe Newswire
1 year ago
SALT LAKE CITY, June 16, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN), along with its subsidiaries Clene and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced ...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Clene Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Clene Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR...
Globe Newswire
1 year ago
SALT LAKE CITY, March 16, 2023 (GLOBE NEWSWIRE) -- Clene, Inc. (Nasdaq: CLNN) along with its subsidiaries Clene and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced ...
Frequently Asked Questions
Frequently Asked Questions
What is Clene Inc share price today?
Can Indians buy Clene Inc shares?
How can I buy Clene Inc shares from India?
Can Fractional shares of Clene Inc be purchased?
What are the documents required to start investing in Clene Inc stocks?
What is today’s traded volume of Clene Inc?
What is today’s market capitalisation of Clene Inc?
What is the 52-Week High and Low Range of Clene Inc?
What percentage is Clene Inc down from its 52-Week High?
What percentage is Clene Inc up from its 52-Week Low?
Current Price
$5
$0.28
(5.93%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.